85 related articles for article (PubMed ID: 6478433)
1. Multimodality therapy of localized unresectable pancreatic adenocarcinoma.
Whittington R; Solin L; Mohiuddin M; Cantor RI; Rosato FE; Biermann WA; Weiss SM; Pajak TF
Cancer; 1984 Nov; 54(9):1991-8. PubMed ID: 6478433
[TBL] [Abstract][Full Text] [Related]
2. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas.
Mohiuddin M; Cantor RJ; Biermann W; Weiss SM; Barbot D; Rosato FE
Int J Radiat Oncol Biol Phys; 1988 Jan; 14(1):79-84. PubMed ID: 3121546
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative radiotherapy in the combined-modality management of pancreatic cancer.
Schuricht AL; Spitz F; Barbot D; Rosato F
Am Surg; 1998 Nov; 64(11):1043-9. PubMed ID: 9798766
[TBL] [Abstract][Full Text] [Related]
4. Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas.
Mohiuddin M; Rosato F; Barbot D; Schuricht A; Biermann W; Cantor R
Int J Radiat Oncol Biol Phys; 1992; 23(2):305-11. PubMed ID: 1587751
[TBL] [Abstract][Full Text] [Related]
5. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.
Mohiuddin M; Regine WF; Stevens J; Rosato F; Barbot D; Biermann W; Cantor R
J Clin Oncol; 1995 Nov; 13(11):2764-8. PubMed ID: 7595736
[TBL] [Abstract][Full Text] [Related]
6. Carcinoma of the pancreas--the Jefferson experience 1975-1988.
Mohiuddin M; Rosato F; Schuricht A; Barbot D; Biermann W; Cantor R
Eur J Surg Oncol; 1994 Feb; 20(1):13-20. PubMed ID: 8131862
[TBL] [Abstract][Full Text] [Related]
7. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
[TBL] [Abstract][Full Text] [Related]
8. Preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for adenocarcinoma of the pancreatic head.
Staley CA; Lee JE; Cleary KR; Abbruzzese JL; Fenoglio CJ; Rich TA; Evans DB
Am J Surg; 1996 Jan; 171(1):118-24; discussion 124-5. PubMed ID: 8554125
[TBL] [Abstract][Full Text] [Related]
9. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
[TBL] [Abstract][Full Text] [Related]
10. Palladium-103: a new radioactive source in the treatment of unresectable carcinoma of the pancreas: a phase I-II study.
Nori D; Merimsky O; Osian AD; Heffernan M; Cortes E; Turner JW
J Surg Oncol; 1996 Apr; 61(4):300-5. PubMed ID: 8628003
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the pancreas: a multimodality approach--a single surgeon's experience (1979-1988).
Schuricht AL; Barbot DJ; Mohiuddin M; Rosato FE
J Surg Oncol; 1991 Sep; 48(1):56-61. PubMed ID: 1716332
[TBL] [Abstract][Full Text] [Related]
12. Hyperfractionated radiation and chemotherapy for unresectable localized adenocarcinoma of the pancreas. The Gastrointestinal Tumor Study Group experience.
Seydel HG; Stablein DM; Leichman LP; Kinzie JJ; Thomas PR
Cancer; 1990 Apr; 65(7):1478-82. PubMed ID: 2138054
[TBL] [Abstract][Full Text] [Related]
13. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
[TBL] [Abstract][Full Text] [Related]
14. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
15. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study.
Yeung RS; Weese JL; Hoffman JP; Solin LJ; Paul AR; Engstrom PF; Litwin S; Kowalyshyn MJ; Eisenberg BL
Cancer; 1993 Oct; 72(7):2124-33. PubMed ID: 8374871
[TBL] [Abstract][Full Text] [Related]
18. Three different intraoperative radiation modalities (electron beam, high-dose-rate brachytherapy, and iodine-125 brachytherapy) in the adjuvant treatment of patients with recurrent colorectal adenocarcinoma.
MartÃnez-Monge R; Nag S; Martin EW
Cancer; 1999 Jul; 86(2):236-47. PubMed ID: 10421259
[TBL] [Abstract][Full Text] [Related]
19. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
20. Surgery and multimodal treatments in pancreatic cancer--a review on the basis of future multimodal treatment concepts.
Link KH; Leder G; Formentini A; Fortnagel G; Kornmann M; Schatz M; Beger HG
Gan To Kagaku Ryoho; 1999 Jan; 26(1):10-40. PubMed ID: 9987495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
